volume 117 | number 5 | May 2009 • Environmental Health Perspectives without an ECG recording between 1999 and 2003, the initial 5-year period in which PM 2.5 data were routinely collected by the U.S. EPA Air Quality System (AQS). The present study focuses on the initial high-quality, resting, standard 12-lead ECGs recorded during this period among the remaining 55,529 participants, all of whom had addresses in the contiguous United States.
ECG methodology. Identical ECGs (MAC PC, Marquette Electronics, Inc., Milwaukee, WI) were used in all clinic sites, and resting, standard 12-lead ECGs were recorded for all participants using strictly standardized procedures. The chest electrodes were located in precise positions. All ECGs were processed in a central ECG laboratory (Epidemiological Cardiology Research Center, Wake Forest University, Winston-Salem, NC), where they were visually inspected for technical errors and inadequate quality. The ECGs were initially processed with the Dalhousie ECG program, and for the present study we reprocessed them with the 2001 version of the GE Marquette 12-SL program (GE Healthcare 2008; Prineas et al. 1982; Rautaharju et al. 1998 ). The Marquette measurement matrix contained several ECG measures of myocardial ischemia that we used as outcome variables in this study.
ST-segment and T-wave amplitudes (microvolt).
We defined lead-specific depth (or height) of the ST segment (ST) 60 msec after the J point and T-wave amplitude (T) relative to the isoelectric line.
ST, T, and ST-T abnormalities. We applied Minnesota Code (MC) criteria to the former interval-scale measures to identify ST abnormality , T abnormality (MC 5.1-5.4), or any ST-T abnormality (MC 4.1-4.4 or MC 5.1-5.4) (Prineas et al. 1982) .
QRS/T angles (degrees).
The frontal plane QRS/T angle was defined as the absolute value of the difference between the frontal plane QRS and T axes (range, -89° to 270°). When > 180°, it was adjusted to the minimal angle as follows: 360° -frontal plane QRS/T angle (Zhang et al. 2007 ). We defined the spatial QRS/T angle as the angle between the mean QRS and T vectors, which we calculated from quasi-orthogonal X, Y, and Z leads reconstructed from the standard ECG leads via matrix transformation (Rautaharju et al. 2006b ).
Air pollutant concentrations, weather variables, and other participant characteristics. We obtained all ambient PM 2.5 concentration data recorded at monitors operating in the contiguous United States during the study from the U.S. EPA AQS. The data included the longitude and latitude of each monitor. We used a semiautomated program built on ArcView GIS (version 8.3) software and its Geostatistical Analyst extension (ESRI, Inc. Redlands, CA) to produce kriging-estimated daily mean concentrations (and their SEs) at each geocoded participant and exam site address from the baseline examination through 2004 (Liao et al. , 2007 Whitsel et al. 2006) . The program relied on a spherical model to perform national-scale, lognormal ordinary kriging and the weighted least-squares method to estimate semivariograms, and ran and cross-validated each daily semivariogram. From the kriging-estimated, daily mean, location-specific PM 2.5 concentrations, we then computed a matrix of 15 short-term pollutant exposures by averaging within overlapping 1-, 2-, and 3-day lag combinations inside a 6-day exposure window beginning 5 days before and ending on the examination date, that is, days 0-5. Associations between PM and ischemia were strongest on days 0-2 (lag 0-2 ), the emphasis of the present report.
We obtained all meteorologic data recorded at relevant stations and times from the National Climatic Data Center (U.S. National Climatic Data Center 2007): ambient temperature (degrees centigrade), dew point (degrees centigrade), and barometric pressures (kilo pascal), as well as station longitudes, latitudes, and altitudes. Daily mean temperature, dew point, and pressure at each geocoded participant and exam site address from baseline to closeout were estimated by averaging daily means across all stations within 50 km, a distance over which their stationto-station correlations exceed 0.90 (Ito et al. 2001) . Thereafter, we computed weather variables at lag 0-2 /lag 3-5 as described above for PM 2.5 .
Self-reported education, medication use, health history, and a variety of other attributes were determined at each visit by standardized participant interview and examination by the WHI staff. Interim health events were identified via standardized medical record review and physician adjudication. Specifically, diabetes was defined by antidiabetic medication use or history; hypertension by antihypertensive medication use, systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or history; body mass index (BMI) as the ratio of weight (kilograms) to height (square meters); hypercholesterolemia by antihyperlipidemic medication use or history; smoking as current, former, or never; chronic lung disease by history of asthma, emphysema, or lung cancer; CHD by antianginal medication use, history of angina, or myocardial infarction and medical record review/adjudication; revascularization by history of coronary artery angioplasty, stent, or bypass and medical record review/adjudication; and congestive heart failure by cardiac glycoside/diuretic use, history, and medical record review/adjudication. Statistical analysis methods. We inspected frequency distributions of all variables for outliers but did not identify influential values. 11 ± 23 QRS/T angles and heart rate Heart rate (beats/min) 66 ± 10 QRS/T angle-spatial ( Initially ignoring the influences of exam site, we explored the associations between ischemia and PM 2.5 in unadjusted linear and logistic regression models. To control for residual confounding by exam season, day of week, time of day, health, and weather, we added temporal, demographic, clinical, and meteorologic charac teristics to the models. We then conducted hierarchical analyses in two stages. In the first stage we used site-specific, adjusted regression models to estimate strength of the ischemia-PM 2.5 associations. The models allowed these estimates to vary among sites. In the second stage we used random effects meta-regression of the site-specific, linear regression coefficients from the first stage to estimate overall strength of the ischemia-PM associations across sites. These weighted, iterative regression models allowed for an additive, between-study component of residual variance estimated via restricted maximum likelihood (Berkey et al. 1995) . We repeated the secondstage analyses by placing uninformative priors on the second-stage parameters and Monte Carlo sampling from the conditional distribution of each unknown using standard Bayesian hierarchical regression algorithms (Robert and Casella 2004) . We evaluated effect measure modification by including cross-product terms for the interaction between PM 2.5 and CHD and its major risk factors at the first stage. Analyses based on logistic and linear regression models adjusting for exam site, and both the random-effects meta-analyses and Bayesian hierarchical regression analyses of the adjusted, site-specific regression coefficients produced similar results. We conducted all analyses using SAS version 9.1 (SAS Institute, Inc., Cary, NC) and MATLAB, version 7.0, software (MathWorks, Inc., Natick, MA). By convention, we report resulting estimates as odds ratios for ST, T, and ST-T abnormalities, or microvolt (µV) changes in ST-segment and T-wave amplitudes associated with 10 µg/m 3 increases in PM 2.5 concentrations.
Results
Of the 55,529 female participants (age range, 52-90 years), 83% were non-Hispanic white, 52% hypertensive, and 20% hypercholesterolemia (Table 1) . Somewhat smaller percentages were current smokers (6%) or had diabetes (8%), CHD (11%), or chronic lung disease (10%). Six percent of the study population had ST abnormalities, and 16% had T abnormalities. Lead-specific ST and T amplitudes were normally distributed (range of means = 4, 64 µV and -14, 349 µV, respectively). Mean ± SD spatial and frontal plane QRS/T angles were 60° ± 28° and 29° ± 27°, with heart rate 66 ± 10 beats/min (Table 2) . Mean PM 2.5 averaged over the first 3 days and second 3 days preceding the ECG (lag 0-2 and lag 3-5 ) were equivalent, as were mean temperature, dew point, and barometric pressure (Table 3) .
In logistic and linear regression models adjusted for demographic, clinical, temporal, and climatic factors, 10 µg/m 3 increases in lag 0-2 PM 2.5 were associated with 4-5% increases in odds ratios (ORs) for ST, T, and ST-T abnormalities, small decreases in lead-specific ST and T amplitudes, and slight increases in the QRS/T angles and heart rate ( Table 4) . We observed decreases in T amplitude in all leads except V1, reaching a minimum of -2.3 µV [95% confidence interval (CI), -5.2 to 0.5 µV] in lead V3 even after controlling for its reported dependence on heart rate (Couderc et al. 2007 ). These observations were consistent across exam sites (Figure 1) . The observed magnitude and direction of effects associated with lag 3-5 PM 2.5 were often weaker and less consistent [Table 4 and Supplemental Material, Tables 1 and 2 (available online at http://www.ehponline. org/members/2009/0800046/suppl.pdf)]. Findings based on unadjusted models and those controlling for randomization status as well as additional participant-and contextuallevel measures of education, occupation, income, and housing were comparable.
Effects of lag 0-2 PM 2.5 were slightly stronger among users versus nonusers of beta-blockers: 10% (1%, 20%) versus 3% (-1%, 8%) increases in the odds of T abnormality (p = 0.098) and -8 (-15, -1) versus -2 (-4, 1) µV decreases in T amplitude in lead V3 (p = 0.076), but in general, there was little suggestion of effect measure modification by CHD or its major risk factors.
Discussion
Judging from the U. 13.8 ± 8 Lag 3
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14. (Allen et al. 2009; Diez Roux et al. 2008; Hoffmann et al. 2007; Kunzli et al. 2005) . The epidemiologic associations observed in these studies are not entirely consistent with one another or collectively as strong as those that may have been anticipated on the basis of recently reported associations between chronic PM exposure and cardiovascular disease (e.g., Miller et al. 2007) , and the role of atherosclerotic mechanisms in the association remains uncertain.
We examined the role of acute, ischemic mechanisms in the association between PM 2.5 and CHD among WHI clinical trial participants with this uncertainty in mind, using ECG-a simple, noninvasive, and underused research tool. In this epidemiologic context, however, we did not limit the examination to characteristics of clinically manifest ischemia (e.g., ≥ 0.1 mV of downsloping ST segment depression and/or deep, symmetrical, precordial T-wave inversion). We opted instead to include minor abnormalities of ventricular repolarization (ST-T abnormalities, ST and T amplitudes) and depolarization (QRS/T angles) to increase sensitivity of the ECG for sub clinical forms of myocardial ischemia. Using this tool, we found that a 10 µg/m 3 increment in lag 0-2 PM 2.5 is associated with 4-5% increased odds of minor ST, T, and ST-T abnormalities, small decreases in ST and T amplitudes across most leads and exam sites, and corresponding increases in QRS/T angles.
Previous findings from the WHI clinical trials cohort include significant prospective relationships between isolated ST-T abnormalities, lead-specific ST and T amplitudes, and wide QRS/T angle at baseline, and CHD mortality, incident CHD, and congestive heart failure (Rautaharju et al. 2006b ). Similar findings also have been described in populationbased settings, such as the Atherosclerosis Risk in Communities study (Zhang et al. 2007 ), Cardiovascular Health Study (Rautaharju et al. 2006a) , and Chicago Western Electric Study (Daviglus et al. 1999) , among others (Engel et al. 2004; Larsen et al. 2002; Okin et al. 2005 Okin et al. , 2007 Schouten et al. 1992 ). However, the clinical utility of these ECG measures remains limited.
Considering the consistent associations between PM 2.5 and the ECG measures of myocardial ischemia observed in this context and the established, prospective association of these measures with CHD, the findings from the present study provide additional support for the hypothesis that subclinical myocardial ischemia has a pathophysiologic role in the adverse effects of acute exposure to PM 2.5 on the heart, including predisposition to ventricular arrhythmogenesis and sudden cardiac death (Rubart and Zipes 2005) . This is the first study to examine such an association in a large popu lation of postmenopausal women. Indeed, prior studies have focused on either animal models of coronary vasoconstriction (Campen et al. 2005; Godleski et al. 2000; Nikolov et al. 2007; Wellenius et al. 2003) or typically small, single-city panels of CHD-burdened, Holtermonitored male participants during exercise (Gold et al. 2005; Henneberger et al. 2005; Lanki et al. 2006; Mills et al. 2007; Pekkanen et al. 2002; Yue et al. 2007) (Table 5 ). The findings described herein are nonetheless consistent with and thereby extend the findings previously described in these populations. They do not imply, however, that ischemia is the sole process by which PM 2.5 exerts its adverse effects on the heart. Autonomic, thrombotic, endothelial, inflammatory, oxidative, and other mechanisms of disease have all been implicated in cardiovascular effects of PM (Chuang et al. 2007; Mills et al. 2007) .
This study has several limitations that may affect interpretation of its findings. First, it is an ancillary study of participants in the WHI clinical trials. Inference is therefore limited to postmenopausal women 52-90 years of age living in the contiguous 48 United States between 1999 and 2003, the initial 5-year period during which PM 2.5 data were routinely collected by the U.S. EPA AQS. Because women in the WHI clinical trials were randomized to estrogen with or without progestin treatment, (Szpiro et al. 2007 ). Third, the associations described herein also may be subject to residual socioeconomic confounding because we defined diabetes and hypercholesterolemia by self-reported history of the disease and/or use of antihyperlipidemic or antidiabetic medications rather than fasting glucose or lipid concentrations, which were only available for 6% site-and race-stratified minority participant oversample.
In the face of these additional limitations, in this study we took several precautions. We carefully established the validity of the geocodes relative to criterion standards ) and the spatial interpolations using standard cross-validation statistics: the prediction error (PE = predicted minus measured pollutant concentration at each monitor site), standardized prediction error (SPE = PE divided by its estimated standard error), root mean square standardized error (RMSS = standard deviation of SPE across sites), root mean square prediction error (RMS = empirical standard error based on the mean square of the predictions), and mathematically calculated standard error (SE). Observed values of PE and SPE near 0 and RMSS near 1, and similarity of RMS and SE provide evidence of model validity (Liao et al. , 2007 . In addition, the study documented modest effects of geo coding and kriging error on PM-CHD associations (Crooks et al. 2008; Whitsel et al. 2006) . Finally, the study demonstrated high reliability of treated diabetes and hypercholesterolemia (Langer et al. 2003) , and we adjusted effect sizes for additional participant-and contextuallevel measures of socio economic status, noting only small changes as a result of adjustment.
Conclusion
We conclude that short-term exposure to PM 2.5 is associated with ECG evidence of myocardial ischemia among postmenopausal women. The principal manifestations include ST-segment and T-wave abnormalities, decreases in ST segment and T amplitude, and increases in QRS/T angles. These findings suggest that the adverse effects of PM 2.5 on CHD risk among postmenopausal women may be related to its subclinical, ischemic effects on the myocardium.
